Stock Radar: This pharma stock breaks out from a 9-month long consolidation phase; likely to fresh record highs
Torrent Pharma signals a potential uptrend. The stock recently emerged from a nine-month consolidation. Experts suggest a buying opportunity for short-term traders. The target price is above Rs 3,900 within 1-2 months. The stock surpassed a key resistance level. Technical indicators support a bullish outlook. Religare Broking recommends accumulating positions.